. The preclinical rationale for the use of insulin-like growth factor-I in amyotrophic lateral sclerosis. Drugs Today (Barc). 1998 Jan;34(1):65-77. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

This paper appears in the following:

Webinars

  1. Insulin Resistance: A Common Axis Linking Alzheimer's, Depression and Metabolism?